Volver a Agenda
Session Chair(s)
Michele Sharp, PHARMD
Senior Director, Global Regulatory Affairs
Eli Lilly and Company, United States
Learning Objective : Describe and discuss internal company roles and processes for targeted drug development resulting in successful registration, differentiated labeling and impactful promotional claims.
Speaker(s)
Panelist
Darshna Patel
Neurocrine Biosciences, Inc., United States
Executive Director, Global Regulatory Affairs
Panelist
Lynette Hopkinson
Vertex Pharmaceuticals Incorporated, United States
Vice President, Commercial Regulatory Affairs, Global Regulatory Affairs
¿Tiene una cuenta?